Literature DB >> 31570916

Bisphosphonates in Perinatally Infected Children and Adolescents With Human Immunodeficiency Virus: Targeting Puberty.

Robert C Kalayjian1, Grace A McComsey2.   

Abstract

Entities:  

Keywords:  bisphoshonates; children and adolescents living with HIV; osteopenia; osteoporosis; puberty

Mesh：

Substances：

Year:  2020        PMID： 31570916      PMCID： PMC9432133          DOI： 10.1093/cid/ciz962

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   20.999


× No keyword cloud information.
  16 in total

Review 1.  Adolescent bone health.

Authors:  Keith J Loud; Catherine M Gordon
Journal:  Arch Pediatr Adolesc Med       Date:  2006-10

Review 2.  Bisphosphonates for postmenopausal osteoporosis.

Authors:  Richard Eastell; Jennifer S Walsh; Nelson B Watts; Ethel Siris
Journal:  Bone       Date:  2011-02-22       Impact factor: 4.398

Review 3.  Treatment of glucocorticoid-induced low bone mineral density in children: a systematic review.

Authors:  Arundathi Jayasena; Navoda Atapattu; Sarath Lekamwasam
Journal:  Int J Rheum Dis       Date:  2015-03       Impact factor: 2.454

4.  Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development.

Authors:  S Mora; P Pitukcheewanont; F R Kaufman; J C Nelson; V Gilsanz
Journal:  J Bone Miner Res       Date:  1999-10       Impact factor: 6.741

5.  Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial.

Authors:  Neville H Golden; Elba A Iglesias; Marc S Jacobson; Dennis Carey; Wendy Meyer; Janet Schebendach; Stanley Hertz; I Ronald Shenker
Journal:  J Clin Endocrinol Metab       Date:  2005-03-22       Impact factor: 5.958

6.  Bone mineral density in children and adolescents with perinatal HIV infection.

Authors:  Linda A DiMeglio; JiaJia Wang; George K Siberry; Tracie L Miller; Mitchell E Geffner; Rohan Hazra; William Borkowsky; Janet S Chen; Laurie Dooley; Kunjal Patel; Russell B van Dyke; Roger A Fielding; Yared Gurmu; Denise L Jacobson
Journal:  AIDS       Date:  2013-01-14       Impact factor: 4.177

7.  Peak bone mass in young HIV-infected patients compared with healthy controls.

Authors:  Eugènia Negredo; Pere Domingo; Elena Ferrer; Vicente Estrada; Adrià Curran; Antonio Navarro; Valentina Isernia; Joaquim Rosales; Núria Pérez-Álvarez; Jordi Puig; Anna Bonjoch; Patricia Echeverría; Daniel Podzamczer; Bonaventura Clotet
Journal:  J Acquir Immune Defic Syndr       Date:  2014-02-01       Impact factor: 3.731

8.  Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.

Authors:  J E Fisher; M J Rogers; J M Halasy; S P Luckman; D E Hughes; P J Masarachia; G Wesolowski; R G Russell; G A Rodan; A A Reszka
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

9.  Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial.

Authors:  Peter L Havens; Charles B Stephensen; Marta D Van Loan; Gertrud U Schuster; Leslie R Woodhouse; Patricia M Flynn; Catherine M Gordon; Cynthia G Pan; Brandy Rutledge; D Robert Harris; Georgine Price; Alyne Baker; William A Meyer; Craig M Wilson; Rohan Hazra; Bill G Kapogiannis; Kathleen Mulligan
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

Review 10.  Systematic review on the incidence of bisphosphonate related osteonecrosis of the jaw in children diagnosed with osteogenesis imperfecta.

Authors:  Anusha Adeline Hennedige; Jap Jayasinghe; Janette Khajeh; Tatiana V Macfarlane
Journal:  J Oral Maxillofac Res       Date:  2014-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.